Updated on 28 January 2013
Indian President Mr Pranab Mukherjee praises 1Clik – A ground breaking insulin injector, glucose monitor and wireless communications system, for management of diabetes
Mumbai: The Indian President, Mr Pranab Mukherjee, and the Governor of the Indian state of Tripura, Dr D Y Patil, praised the latest ground breaking diabetes device developed by Rana Arefieg of Global Innovations, at a private event held for inauguration of "DY Patil Knowledge City" honoring the Governor of Tripura.
The President was particularly by impressed by the 1Clik, an insulin injector, glucose monitor and wireless communications system. The President also reaffirmed the 'importance of innovation' in his speech at the event. He said, "There is a real need for such innovative medical devices to be made available to the Indian population at affordable prices."
The 1Clik auto injector delivery system combines blood glucose tester, insulin calculator, insulin injector, and secure wireless reporting to the cloud in one easy to use device keeping patients, doctors and family members informed. Key features of 1Clik, include seamlessly integrating glucose monitoring, insulin injections, emergency monitoring and real time patient information data; integrating with electronic medical records; and reducing complications from too high or too low blood sugar levels among others.
Governor Dr D Y Patil who is an educator and leader of the State of Tripura, spoke directly to Global Innovations Advisor Dr Mak Jawadekar, a world renowned R&D leader and formerly of Pfizer Global R & D about the immense potential to save lives with 1Clik and reduce the overall cost of diabetes on society, which is an estimated $100 billion per year.
Dr Mak presented 1Clik during the key note address at the Pune branch of the Diabetic Association of India (DAI) conference, which was attended by hundreds of diabetes subject matter experts and key opinion leaders in both medical and technology fields. The device was very well received by the experts and is expected to change the face of diabetes management for generations to come.